LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 95

Search options

  1. Article ; Online: Editorial: MAIT cells come of age.

    Corbett, Alexandra J / Ussher, James E / Hinks, Timothy S C

    Frontiers in immunology

    2023  Volume 14, Page(s) 1281881

    MeSH term(s) Mucosal-Associated Invariant T Cells
    Language English
    Publishing date 2023-09-06
    Publishing country Switzerland
    Document type Editorial
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2023.1281881
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: The Immune Response to SARS-CoV-2 and Variants of Concern.

    Torbati, Elham / Krause, Kurt L / Ussher, James E

    Viruses

    2021  Volume 13, Issue 10

    Abstract: At the end of 2019 a newly emerged betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was identified as the cause of an outbreak of severe pneumonia, subsequently termed COVID-19, in a number of patients in Wuhan, China. ... ...

    Abstract At the end of 2019 a newly emerged betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was identified as the cause of an outbreak of severe pneumonia, subsequently termed COVID-19, in a number of patients in Wuhan, China. Subsequently, SARS-CoV-2 rapidly spread globally, resulting in a pandemic that has to date infected over 200 million individuals and resulted in more than 4.3 million deaths. While SARS-CoV-2 results in severe disease in 13.8%, with increasing frequency of severe disease with age, over 80% of infections are asymptomatic or mild. The immune response is an important determinant of outcome following SARS-CoV-2 infection. While B cell and T cell responses are associated with control of infection and protection against subsequent challenge with SARS-CoV-2, failure to control viral replication and the resulting hyperinflammation are associated with severe COVID-19. Towards the end of 2020, several variants of concern emerged that demonstrate increased transmissibility and/or evasion of immune responses from prior SARS-CoV-2 infection. This article reviews what is known about the humoral and cellular immune responses to SARS-CoV-2 and how mutation and structural/functional changes in the emerging variants of concern impact upon the immune protection from prior infection or vaccination.
    MeSH term(s) COVID-19/immunology ; Humans ; Immunity/immunology ; Pandemics/prevention & control ; SARS-CoV-2/immunology
    Language English
    Publishing date 2021-09-23
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2516098-9
    ISSN 1999-4915 ; 1999-4915
    ISSN (online) 1999-4915
    ISSN 1999-4915
    DOI 10.3390/v13101911
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: The persistence of neutralising antibodies up to 11 months after SARS CoV-2 infection in the southern region of New Zealand.

    McGregor, Reuben / Craigie, Alyson / Jack, Susan / Upton, Arlo / Moreland, Nicole J / Ussher, James E

    The New Zealand medical journal

    2022  Volume 135, Issue 1550, Page(s) 162–166

    MeSH term(s) Antibodies, Neutralizing ; COVID-19 ; Humans ; New Zealand/epidemiology ; SARS-CoV-2 ; Severe Acute Respiratory Syndrome
    Chemical Substances Antibodies, Neutralizing
    Language English
    Publishing date 2022-02-25
    Publishing country New Zealand
    Document type Letter
    ZDB-ID 390590-1
    ISSN 1175-8716 ; 0028-8446 ; 0110-7704
    ISSN (online) 1175-8716
    ISSN 0028-8446 ; 0110-7704
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Biological functions of MAIT cells in tissues.

    Klenerman, Paul / Hinks, Timothy S C / Ussher, James E

    Molecular immunology

    2020  Volume 130, Page(s) 154–158

    Abstract: Mucosal associated invariant T (MAIT) cells have a recognised innate-like capacity for antibacterial host defence, consequent on the specificity of their T cell receptor (TCR) for small molecule metabolites produced by a range of prokaryotic and fungal ... ...

    Abstract Mucosal associated invariant T (MAIT) cells have a recognised innate-like capacity for antibacterial host defence, consequent on the specificity of their T cell receptor (TCR) for small molecule metabolites produced by a range of prokaryotic and fungal species, their effector memory phenotype, and their expression of cytotoxic molecules. However, recent studies have identified at least two other important functions of MAIT cells in antiviral immunity and in tissue homeostasis and repair. Each are related to distinct transcriptional programmes, which are activated differentially according to the specific immune context. Here we discuss these diverse functions, we review the evidence for the newly identified role of MAIT cells in promoting tissue repair, and we discuss emerging data pointing to the future directions of MAIT cell research including roles in cancer, in antiviral immunity and recent studies in the immune response to SARS-CoV-2 infection. Overall these studies have made us aware of the potential for pleiotropic roles of MAIT cells and related cell populations in micee and humans, and have created a simple and attractive new paradigm for regulation in barrier tissues, where antigen and tissue damage are sensed, integrated and interpreted.
    MeSH term(s) Animals ; Bacterial Infections/immunology ; Homeostasis ; Humans ; Mucosal-Associated Invariant T Cells/cytology ; Mucosal-Associated Invariant T Cells/immunology ; Mucosal-Associated Invariant T Cells/metabolism ; Neoplasms/immunology ; Receptors, Antigen, T-Cell ; Virus Diseases/immunology
    Chemical Substances Receptors, Antigen, T-Cell
    Language English
    Publishing date 2020-12-25
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 424427-8
    ISSN 1872-9142 ; 0161-5890
    ISSN (online) 1872-9142
    ISSN 0161-5890
    DOI 10.1016/j.molimm.2020.12.017
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Antimicrobial Resistance in New Zealand-A One Health Perspective.

    Pattis, Isabelle / Weaver, Louise / Burgess, Sara / Ussher, James E / Dyet, Kristin

    Antibiotics (Basel, Switzerland)

    2022  Volume 11, Issue 6

    Abstract: Antimicrobial resistance (AMR) is an increasing global threat that affects human, animal and, often less acknowledged, environmental health. This complex issue requires a multisectoral One Health approach to address the interconnectedness of humans, ... ...

    Abstract Antimicrobial resistance (AMR) is an increasing global threat that affects human, animal and, often less acknowledged, environmental health. This complex issue requires a multisectoral One Health approach to address the interconnectedness of humans, animals and the natural environment. The prevalence of AMR in these reservoirs varies widely among countries and thus often requires a country-specific approach. In New Zealand (NZ), AMR and antimicrobial usage in humans are relatively well-monitored and -understood, with high human use of antimicrobials and the frequency of resistant pathogens increasing in hospitals and the community. In contrast, on average, NZ is a low user of antimicrobials in animal husbandry systems with low rates of AMR in food-producing animals. AMR in New Zealand's environment is little understood, and the role of the natural environment in AMR transmission is unclear. Here, we aimed to provide a summary of the current knowledge on AMR in NZ, addressing all three components of the One Health triad with a particular focus on environmental AMR. We aimed to identify knowledge gaps to help develop research strategies, especially towards mitigating AMR in the environment, the often-neglected part of the One Health triad.
    Language English
    Publishing date 2022-06-07
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2681345-2
    ISSN 2079-6382
    ISSN 2079-6382
    DOI 10.3390/antibiotics11060778
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Development of real-time RT-PCR assays to detect measles virus on the Hologic Panther Fusion® System.

    Grant, Jenny / Atapattu, Nadika / Dilcher, Meik / Tan, Chor Ee / Elvy, Juliet / Ussher, James E

    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology

    2022  Volume 159, Page(s) 105355

    Abstract: Background: In 2019, Aotearoa New Zealand (NZ) experienced its worst measles outbreak since 1997. Due to declining childhood vaccination rates since the beginning of the SARS-CoV-2 pandemic, NZ is at serious risk of another major measles outbreak. Our ... ...

    Abstract Background: In 2019, Aotearoa New Zealand (NZ) experienced its worst measles outbreak since 1997. Due to declining childhood vaccination rates since the beginning of the SARS-CoV-2 pandemic, NZ is at serious risk of another major measles outbreak. Our laboratory provides diagnostic services to NZ's Southern region. In 2019 the Southern region experienced the greatest number of cases outside of Auckland and Northland, however we did not have a validated measles PCR assay in our laboratory.
    Objectives: We sought to develop reverse transcription real-time polymerase chain reaction (RT-PCR) assays for measles on the Hologic Panther Fusion® System by utilising its open access function.
    Study design: Previously published real-time RT-PCR assays were modified and optimised to detect wild-type measles virus (LDT-Mea), and the vaccine strain of measles virus (LDT-MeaVacA), on the Hologic Panther Fusion® System. The assays were clinically validated.
    Results: The LDT-Mea assay has a limit of detection (LoD) of 0.1 CCID
    Conclusion: We have successfully adapted and validated for diagnostic use on the Hologic Panther Fusion® System previously published assays to detect wild-type and vaccine strains of the measles virus. The implementation of measles testing on this system will greatly improve the turn-around time for measles testing, and better support the measles public health response, for our region.
    MeSH term(s) Humans ; Measles virus/genetics ; COVID-19 ; SARS-CoV-2/genetics ; Reverse Transcriptase Polymerase Chain Reaction ; Real-Time Polymerase Chain Reaction ; Measles/diagnosis ; Measles/epidemiology ; Sensitivity and Specificity ; COVID-19 Testing
    Language English
    Publishing date 2022-12-16
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 1446080-4
    ISSN 1873-5967 ; 1386-6532
    ISSN (online) 1873-5967
    ISSN 1386-6532
    DOI 10.1016/j.jcv.2022.105355
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Disseminated Erysipelothrix rhusiopathiae with Secondary Prosthetic Hip Joint Infection: A Case of Successful Identification and Management in a Regional Hospital.

    McCall, Matthew / Arnold, Brendan / Ussher, James / Sandiford, N Amir

    JBJS case connector

    2023  Volume 13, Issue 4

    Abstract: ... with fevers and unilateral hip pain. Erysipelothrix rhusiopathiae (E. rhusiopathiae) was isolated on hip ... aspirate and blood cultures. E. rhusiopathiae is a well-recognized zoonotic infection in humans ... of prosthetic joint infection secondary to E. rhusiopathiae, particularly microbiological identification ...

    Abstract Case: This article reports a case of a 72-year-old man with bilateral total hip joint replacements who suffered cuts to his hands while butchering a wild boar. He presented to the emergency department with fevers and unilateral hip pain. Erysipelothrix rhusiopathiae (E. rhusiopathiae) was isolated on hip aspirate and blood cultures. E. rhusiopathiae is a well-recognized zoonotic infection in humans, particularly in at-risk hosts, most commonly infecting swine. Infection is spread by ingestion or through skin abrasion.
    Conclusion: This illustrates an example of successful operative and perioperative management of prosthetic joint infection secondary to E. rhusiopathiae, particularly microbiological identification, within a multispecialty team of physicians and surgeons.
    MeSH term(s) Male ; Humans ; Animals ; Swine ; Aged ; Erysipelothrix ; Erysipelothrix Infections/microbiology ; Arthritis, Infectious/microbiology ; Arthroplasty, Replacement ; Hip Joint/surgery
    Language English
    Publishing date 2023-10-19
    Publishing country United States
    Document type Case Reports ; Journal Article
    ISSN 2160-3251
    ISSN (online) 2160-3251
    DOI 10.2106/JBJS.CC.23.00301
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Expression and trafficking of MR1.

    Lamichhane, Rajesh / Ussher, James E

    Immunology

    2017  Volume 151, Issue 3, Page(s) 270–279

    Abstract: MHC class I-related gene protein (MR1) is a non-polymorphic MHC class IB antigen-presenting molecule that is the restricting molecule for mucosal-associated invariant T (MAIT) cells, a prominent population of innate-like antibacterial T cells. The MAIT ... ...

    Abstract MHC class I-related gene protein (MR1) is a non-polymorphic MHC class IB antigen-presenting molecule that is the restricting molecule for mucosal-associated invariant T (MAIT) cells, a prominent population of innate-like antibacterial T cells. The MAIT cell-MR1 axis represents a new paradigm in antigen presentation, with the MR1 ligand derived from vitamin B compounds or their metabolic precursors. Many bacteria and some fungi produce the activating ligand for MR1. In evolution, MR1 is highly conserved in most, but not all, mammals. In humans and rodents it is expressed in a broad range of cell types, both haematopoietic and non-haematopoietic, although cell surface expression has been difficult to detect. Although MR1 trafficking shares features with both the MHC class I and MHC class II pathways, it is distinct. Several strands of evidence suggest that the intracellular location where MR1 is loaded differs for soluble ligand and for ligand derived from intact bacteria. The regulation of MR1 surface expression may also vary between different cell types. This paper will review what is currently known about the expression and trafficking of MR1 and propose a model for the loading and trafficking of MR1.
    MeSH term(s) Amino Acid Sequence ; Animals ; Conserved Sequence ; Evolution, Molecular ; Gene Expression Regulation ; Histocompatibility Antigens Class I/genetics ; Histocompatibility Antigens Class I/immunology ; Histocompatibility Antigens Class I/metabolism ; Humans ; Ligands ; Minor Histocompatibility Antigens/genetics ; Minor Histocompatibility Antigens/immunology ; Minor Histocompatibility Antigens/metabolism ; Protein Transport ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Signal Transduction ; T-Lymphocytes/immunology ; T-Lymphocytes/metabolism
    Chemical Substances Histocompatibility Antigens Class I ; Ligands ; MR1 protein, human ; Minor Histocompatibility Antigens ; RNA, Messenger
    Language English
    Publishing date 2017
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 80124-0
    ISSN 1365-2567 ; 0019-2805 ; 0953-4954
    ISSN (online) 1365-2567
    ISSN 0019-2805 ; 0953-4954
    DOI 10.1111/imm.12744
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: The Immune Response to SARS-CoV-2 and Variants of Concern

    Torbati, Elham / Krause, Kurt L. / Ussher, James E.

    Viruses. 2021 Sept. 23, v. 13, no. 10

    2021  

    Abstract: At the end of 2019 a newly emerged betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was identified as the cause of an outbreak of severe pneumonia, subsequently termed COVID-19, in a number of patients in Wuhan, China. ... ...

    Abstract At the end of 2019 a newly emerged betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was identified as the cause of an outbreak of severe pneumonia, subsequently termed COVID-19, in a number of patients in Wuhan, China. Subsequently, SARS-CoV-2 rapidly spread globally, resulting in a pandemic that has to date infected over 200 million individuals and resulted in more than 4.3 million deaths. While SARS-CoV-2 results in severe disease in 13.8%, with increasing frequency of severe disease with age, over 80% of infections are asymptomatic or mild. The immune response is an important determinant of outcome following SARS-CoV-2 infection. While B cell and T cell responses are associated with control of infection and protection against subsequent challenge with SARS-CoV-2, failure to control viral replication and the resulting hyperinflammation are associated with severe COVID-19. Towards the end of 2020, several variants of concern emerged that demonstrate increased transmissibility and/or evasion of immune responses from prior SARS-CoV-2 infection. This article reviews what is known about the humoral and cellular immune responses to SARS-CoV-2 and how mutation and structural/functional changes in the emerging variants of concern impact upon the immune protection from prior infection or vaccination.
    Keywords B-lymphocytes ; COVID-19 infection ; Severe acute respiratory syndrome coronavirus 2 ; T-lymphocytes ; disease severity ; immune response ; mutation ; pandemic ; pneumonia ; vaccination ; virus replication ; China
    Language English
    Dates of publication 2021-0923
    Publishing place Multidisciplinary Digital Publishing Institute
    Document type Article
    ZDB-ID 2516098-9
    ISSN 1999-4915
    ISSN 1999-4915
    DOI 10.3390/v13101911
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  10. Article ; Online: New Zealand's science-led response to the SARS-CoV-2 pandemic.

    Geoghegan, Jemma L / Moreland, Nicole J / Le Gros, Graham / Ussher, James E

    Nature immunology

    2021  Volume 22, Issue 3, Page(s) 262–263

    MeSH term(s) Advisory Committees ; COVID-19/epidemiology ; COVID-19/prevention & control ; COVID-19/transmission ; COVID-19 Vaccines/therapeutic use ; Communicable Disease Control ; Communicable Diseases, Imported ; Disease Transmission, Infectious ; Emigration and Immigration ; Humans ; Mass Screening ; New Zealand/epidemiology ; Public Health ; Public Policy ; SARS-CoV-2
    Chemical Substances COVID-19 Vaccines
    Language English
    Publishing date 2021-02-24
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2016987-5
    ISSN 1529-2916 ; 1529-2908
    ISSN (online) 1529-2916
    ISSN 1529-2908
    DOI 10.1038/s41590-021-00872-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top